Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.36 |
| ▸ | CA12 | O43570 | 3/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | PHGDH | O43175 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | PTPRB | P23467 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.32 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.32 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.32 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13192452 | 0.82 | CA2 (0.42) | CA14CA12RECQLCA1CA2 | |
| SCHEMBL18929976 | 0.80 | CA14 (0.36) | CA14CA12RECQLCA1CA2 | |
| SCHEMBL28125570 | 0.80 | CA14 (0.36) | CA14CA12RECQLCA1CA2 | |
| SCHEMBL1119855 | 0.80 | CA14 (0.36) | CA14CA12RECQLCA1CA2 | |
| SCHEMBL13631860 | 0.80 | CA14 (0.36) | CA14CA12RECQLCA1CA2 | |
| SCHEMBL26714018 | 0.78 | CA14 (0.35) | CA14CA12RECQLCA1CA2 | |
| SCHEMBL21012368 | 0.77 | ALDH1A1 (0.42) | CA12RECQLCA1CA2CA9 | |
| SCHEMBL13978750 | 0.77 | CA2 (0.41) | CA14CA12RECQLCA1CA2 | |
| SCHEMBL15381953 | 0.77 | TP53 (0.33) | CA14CA12CA1CA2CA9 | |
| SCHEMBL11421265 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130269568-A1 | DERIVATIVES FOR PERFLUOROALKOXY SULFOSUCCINATES AS SURFACTANTS | MERCK PATENT GMBH (DE) | 2013-10-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130269568-A1 | DERIVATIVES FOR PERFLUOROALKOXY SULFOSUCCINATES AS SURFACTANTS | PFAS, SFXN3, FGB | CA14 1187/4885CA12 1526/4885RECQL 3443/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.